PRECISION MEDICINE LEADERS’ SUMMIT 2019 – EAST

PRECISION MEDICINE LEADERS’ SUMMIT 2019 – EAST

PRECISION MEDICINE LEADERS’ SUMMIT 2019 – EAST

Precision Medicine Clinical Trials and Novel Designs: Levering Data, ‘Omics’, AI and Policy

Moderator: Arturo Loaiza Bonilla, MD, MSEd, FACP, Vice Chair, Department of Medical Oncology, CTCA

Panelists: Selin Kurnaz, PhD,  CEO – Massive Bio, Richard Schilsky, MD, FACP, FASCO, FSCT, Senior Vice President and Chief Medical Officer, ASCO, Gary Palmer, MD, Chief Medical Officer, Tempus

The paradigm changes from the ‘phenotype-to-genotype’ to the ‘genotype-to-phenotype’ approach has revolutionized R&D and Clinical trials in oncology and other diseases. This panel will discuss the impact of novel approaches to clinical trial design, including the use of technology, biomarker data and the current regulatory landscape which is moving the needle forward in earlier access and approval of promising compounds. The audience will be able to learn further about ‘basket’, ‘umbrella’, ‘seamless’, ‘adaptive’ design trials, synthetic control arms, ‘Just-In-Time (JIT) trials, as will have the opportunity to how different stakeholders are adapting to recent FDA policies and regulations for their R&D and clinical trial matching enrollment.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial
See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

See if you pre-qualify for clinical trials.

Our specialized team will contact you within 24 hours.

[EN] Blog Details - United States & Canada - English

Your Birthday



By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Most Popular